Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-22-010620
Filing Date
2022-04-21
Accepted
2022-04-21 16:05:46
Documents
2
Period of Report
2021-04-20

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1558
2 ex-24.htm EX-24 13761
  Complete submission text file 0001493152-22-010620.txt   16890
Mailing Address P.O. BOX 2161 WAKE FOREST NC 27588
Business Address P.O. BOX 2161 WAKE FOREST NC 27588 919-578-5901
Adhera Therapeutics, Inc. (Issuer) CIK: 0000737207 (see all company filings)

EIN.: 112658569 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 8000 INNOVATION PARKWAY BAON ROUGE LA 70820
Business Address
Waerness Trond Kydd (Reporting) CIK: 0001884098 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-13789 | Film No.: 22841446